Document is current
Any future updates will be listed below
-
Authors
Leap, Katie
Lepelletier, Anthony
Liorzou, Eulalie
Doridot, Ludivine
Brulport, Axelle
Berthelot, Camille
-
Funding
Funding for this research was provided by:
European Research Council (101078556)
European Research Council (No 851360)
Fondation pour la Recherche sur l’Endométriose, Endofrance (FRE202112014887)
Institut Pasteur (G5 package)
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 19 June 2026
First Online: 30 June 2026
Declarations
:
: The authors declare no competing interests.
: The study is part of clinical trial C18-19 EVOMENS sponsored by Inserm. It was approved by the French National Institute for Health and Medical Research (INSERM, IDRCB 2019-A01089-48) and the Ethics Committee for the protection of individuals Est V (ID: 20/13 / SI 19.11.26.65936) on March 20, 2020. This study was also registered on the Clinical Trial website under the number NCT04085835. All study participants gave their informed, written consent to participation, in line with French ethical guidelines.
: Not applicable
